Professor Chris Twelves, clinical director at the Leeds Teaching Hospitals NHS Trust NIHR Leeds CRF and Professor of Clinical Cancer Pharmacology and Oncology at the University of Leeds said: “This investigational cancer vaccine works by training the immune system to fight the cancer, which could be transformational for patients by slowing spread of the cancer and hopefully controlling their disease for longer.
Trending
- The Story of Immune Checkpoint Inhibitors and Immunotherapy
- Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy
- Considering CAR T vs Bispecific Antibodies in R/R Follicular Lymphoma
- The RNA-binding protein RALY promotes ATM activation by stabilizing Tip60
- The Day I Realized Love Couldn’t Save Someone
- The 16 Most Painful Health Conditions in the World| U.S. News
- Breast Surgeon Explains How Her Team Avoided Delays After Needle Recall
- Focal HIFU/Cryotherapy Show Durable 10-Year Control in Prostate Cancer
Tuesday, July 21
